Regeneron antibody cocktail approved by european commission to treat and prevent covid-19

Tarrytown, n.y., nov. 12, 2021 /prnewswire/ -- ec marketing authorization follows approvals in japan, australia and the uk regeneron pharmaceuticals, inc. (nasdaq: regn) today announced that the european commission (ec) has approved the casirivimab and imdevimab antibody cocktail, known as regen-cov® in the u.s. and ronapreve™ in the european union (eu) and other countries.
REGN Ratings Summary
REGN Quant Ranking